News for OXIS INTERNATIONAL INC (OXIS)

News for OXIS INTERNATIONAL INC
Date Headline
Aug 21, 2017 08:00 AM GT Biopharma, Inc. Announces Reverse Stock Spilt As Part of Oxis-Georgetown Planned Merger
Aug 10, 2017 12:25 PM Are These 3 Biotech Stocks On Your Radar Today?
Aug 10, 2017 08:00 AM GT Biopharma (OXIS) Executives to Present at Rodman & Renshaw Conference in New York
Aug 09, 2017 11:15 AM 3 Biotech Stocks Under the Microscope on Wednesday 8/9/17
Aug 07, 2017 08:00 AM GT Biopharma, Inc. (Oxis) Announces Corporate Update Conference Call With Incoming CEO Dr. Kathleen Clarence-Smith and Chairman Anthony Cataldo
Aug 02, 2017 08:00 AM GT Biopharma (OXIS) Announces Enrollment of Fourth Patient in FDA Phase 2 Trial of Cancer Drug OXS-1550
Jul 25, 2017 08:30 AM Oxis Releases Additional Details about Acquisition of Georgetown Translational Pharmaceuticals, Oxis to Change Name to "GT Biopharma, Inc."
Jul 05, 2017 08:15 AM USPTO Approves and Issues Patent for Oxis-4235 to Treat Multiple Myeloma
Jun 26, 2017 08:00 AM Oxis Agrees to Acquire Georgetown Translational Pharmaceuticals, Appoints New Chief Executive Officer and Chief Medical Officer
Jun 13, 2017 08:30 AM Oxis Enters into a Co-Development Partnership Agreement with Altor Bioscience for Novel TriKE Therapeutic